{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:21:31Z","timestamp":1790842891124,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI116274"],"award-info":[{"award-number":["AI116274"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI129769"],"award-info":[{"award-number":["AI129769"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Health","award":["AI120756"],"award-info":[{"award-number":["AI120756"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The binding of HIV-1 Envelope glycoproteins (Env) to host receptor CD4 exposes vulnerable conserved epitopes within the co-receptor binding site (CoRBS) which are required for the engagement of either CCR5 or CXCR4 co-receptor to allow HIV-1 entry. Antibodies against this region have been implicated in the protection against HIV acquisition in non-human primate (NHP) challenge studies and found to act synergistically with antibodies of other specificities to deliver effective Fc-mediated effector function against HIV-1-infected cells. Here, we describe the structure and function of N12-i2, an antibody isolated from an HIV-1-infected individual, and show how the unique structural features of this antibody allow for its effective Env recognition and Fc-mediated effector function.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>N12-i2 binds within the CoRBS utilizing two adjacent sulfo-tyrosines (TYS) for binding, one of which binds to a previously unknown TYS binding pocket formed by gp120 residues of high sequence conservation among HIV-1 strains. Structural alignment with gp120 in complex with the co-receptor CCR5 indicates that the new pocket corresponds to TYS at position 15 of CCR5. In addition, structure-function analysis of N12-i2 and other CoRBS-specific antibodies indicates a link between modes of antibody binding within the CoRBS and Fc-mediated effector activities. The efficiency of antibody-dependent cellular cytotoxicity (ADCC) correlated with both the level of antibody binding and the mode of antibody attachment to the epitope region, specifically with the way the Fc region was oriented relative to the target cell surface. Antibodies with poor Fc access mediated the poorest ADCC whereas those with their Fc region readily accessible for interaction with effector cells mediated the most potent ADCC.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Our data identify a previously unknown binding site for TYS within the assembled CoRBS of the HIV-1 virus. In addition, our combined structural-modeling-functional analyses provide new insights into mechanisms of Fc-effector function of antibodies against HIV-1, in particular, how antibody binding to Env antigen affects the efficiency of ADCC response.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12915-020-00819-y","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T16:05:38Z","timestamp":1595347538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Defining rules governing recognition and Fc-mediated effector functions to the HIV-1 co-receptor binding site"],"prefix":"10.1186","volume":"18","author":[{"given":"William D.","family":"Tolbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah","family":"Sherburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelakshi","family":"Gohain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Flinko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishanu","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Finzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George K.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0594-5057","authenticated-orcid":false,"given":"Marzena","family":"Pazgier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"issue":"4","key":"819_CR1","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jmb.2011.04.042","volume":"410","author":"MA Checkley","year":"2011","unstructured":"Checkley MA, Luttge BG, Freed EO. HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. J Mol Biol. 2011;410(4):582\u2013608.","journal-title":"J Mol Biol"},{"issue":"5371","key":"819_CR2","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1126\/science.280.5371.1884","volume":"280","author":"R Wyatt","year":"1998","unstructured":"Wyatt R, Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science. 1998;280(5371):1884\u20138.","journal-title":"Science"},{"issue":"5996","key":"819_CR3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/312763a0","volume":"312","author":"AG Dalgleish","year":"1984","unstructured":"Dalgleish AG, et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 1984;312(5996):763\u20137.","journal-title":"Nature"},{"issue":"7","key":"819_CR4","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0092-8674(00)81313-6","volume":"85","author":"H Choe","year":"1996","unstructured":"Choe H, et al. The \u03b2-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 1996;85(7):1135\u201348.","journal-title":"Cell"},{"issue":"5263","key":"819_CR5","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.272.5263.872","volume":"272","author":"Y Feng","year":"1996","unstructured":"Feng Y, et al. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 1996;272(5263):872\u20137.","journal-title":"Science"},{"issue":"6","key":"819_CR6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/157016207782418560","volume":"5","author":"AL DeVico","year":"2007","unstructured":"DeVico AL. CD4-induced epitopes in the HIV envelope glycoprotein, gp120. Curr HIV Res. 2007;5(6):561\u201371.","journal-title":"Curr HIV Res"},{"issue":"22","key":"819_CR7","doi-asserted-by":"crossref","first-page":"11096","DOI":"10.1128\/JVI.75.22.11096-11105.2001","volume":"75","author":"CM Finnegan","year":"2001","unstructured":"Finnegan CM, et al. Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion. J Virol. 2001;75(22):11096\u2013105.","journal-title":"J Virol"},{"issue":"3","key":"819_CR8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/COH.0000000000000055","volume":"9","author":"GK Lewis","year":"2014","unstructured":"Lewis GK, et al. Epitope target structures of Fc-mediated effector function during HIV-1 acquisition. Curr Opin HIV AIDS. 2014;9(3):263.","journal-title":"Curr Opin HIV AIDS"},{"issue":"16","key":"819_CR9","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1089\/08892220260387959","volume":"18","author":"S-H Xiang","year":"2002","unstructured":"Xiang S-H, et al. Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies. AIDS Res Hum Retrovir. 2002;18(16):1207\u201317.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"5","key":"819_CR10","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1128\/JVI.03230-13","volume":"88","author":"M Veillette","year":"2014","unstructured":"Veillette M, et al. Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity. J Virol. 2014;88(5):2633\u201344.","journal-title":"J Virol"},{"issue":"9","key":"819_CR11","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1084\/jem.20042510","volume":"201","author":"JM Decker","year":"2005","unstructured":"Decker JM, et al. Antigenic conservation and immunogenicity of the HIV coreceptor binding site. J Exp Med. 2005;201(9):1407\u201319.","journal-title":"J Exp Med"},{"issue":"6686","key":"819_CR12","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/31405","volume":"393","author":"PD Kwong","year":"1998","unstructured":"Kwong PD, et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature. 1998;393(6686):648\u201359.","journal-title":"Nature"},{"issue":"7","key":"819_CR13","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1128\/jvi.67.7.3978-3988.1993","volume":"67","author":"M Thali","year":"1993","unstructured":"Thali M, et al. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J Virol. 1993;67(7):3978\u201388.","journal-title":"J Virol"},{"issue":"6686","key":"819_CR14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/31514","volume":"393","author":"R Wyatt","year":"1998","unstructured":"Wyatt R, et al. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature. 1998;393(6686):705\u201311.","journal-title":"Nature"},{"issue":"1","key":"819_CR15","doi-asserted-by":"crossref","first-page":"E69","DOI":"10.1073\/pnas.1217609110","volume":"110","author":"Y Guan","year":"2013","unstructured":"Guan Y, et al. Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding. Proc Natl Acad Sci U S A. 2013;110(1):E69\u201378.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"819_CR16","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1089\/aid.2016.0299","volume":"33","author":"GK Lewis","year":"2017","unstructured":"Lewis GK, et al. Beyond viral neutralization. AIDS Res Hum Retrovir. 2017;33(8):760\u20134.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"1","key":"819_CR17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/imr.12510","volume":"275","author":"GK Lewis","year":"2017","unstructured":"Lewis GK, Pazgier M, DeVico AL. Survivors remorse: antibody-mediated protection against HIV-1. Immunol Rev. 2017;275(1):271\u201384.","journal-title":"Immunol Rev"},{"issue":"5","key":"819_CR18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2174\/1570162X113116660059","volume":"11","author":"J Pollara","year":"2013","unstructured":"Pollara J, et al. Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses. Curr HIV Res. 2013;11(5):378\u201387.","journal-title":"Curr HIV Res"},{"key":"819_CR19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ebiom.2016.09.004","volume":"12","author":"J Richard","year":"2016","unstructured":"Richard J, et al. Co-receptor binding site antibodies enable CD4-mimetics to expose conserved anti-cluster a ADCC epitopes on HIV-1 envelope glycoproteins. EBioMedicine. 2016;12:208\u201318.","journal-title":"EBioMedicine"},{"issue":"6","key":"819_CR20","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1128\/JVI.72.6.4694-4703.1998","volume":"72","author":"N Sullivan","year":"1998","unstructured":"Sullivan N, et al. CD4-induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. J Virol. 1998;72(6):4694\u2013703.","journal-title":"J Virol"},{"issue":"7739","key":"819_CR21","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41586-018-0804-9","volume":"565","author":"MM Shaik","year":"2019","unstructured":"Shaik MM, et al. Structural basis of coreceptor recognition by HIV-1 envelope spike. Nature. 2019;565(7739):318\u201323.","journal-title":"Nature"},{"issue":"44","key":"819_CR22","doi-asserted-by":"crossref","first-page":"17477","DOI":"10.1073\/pnas.0707399104","volume":"104","author":"A DeVico","year":"2007","unstructured":"DeVico A, et al. Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens. Proc Natl Acad Sci U S A. 2007;104(44):17477\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"819_CR23","doi-asserted-by":"crossref","first-page":"E992","DOI":"10.1073\/pnas.1423669112","volume":"112","author":"TR Fouts","year":"2015","unstructured":"Fouts TR, et al. Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection. Proc Natl Acad Sci U S A. 2015;112(9):E992\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"819_CR24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.virol.2014.10.001","volume":"0","author":"MA Thomas","year":"2014","unstructured":"Thomas MA, et al. HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaques. Virology. 2014;0:81\u201392.","journal-title":"Virology"},{"issue":"21","key":"819_CR25","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1128\/JVI.01023-12","volume":"86","author":"M Bonsignori","year":"2012","unstructured":"Bonsignori M, et al. Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family. J Virol. 2012;86(21):11521\u201332.","journal-title":"J Virol"},{"issue":"14","key":"819_CR26","doi-asserted-by":"crossref","first-page":"7715","DOI":"10.1128\/JVI.00156-14","volume":"88","author":"J Pollara","year":"2014","unstructured":"Pollara J, et al. HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities. J Virol. 2014;88(14):7715\u201326.","journal-title":"J Virol"},{"issue":"24","key":"819_CR27","doi-asserted-by":"crossref","first-page":"11427","DOI":"10.1128\/JVI.74.24.11427-11436.2000","volume":"74","author":"TR Fouts","year":"2000","unstructured":"Fouts TR, et al. Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex. J Virol. 2000;74(24):11427\u201336.","journal-title":"J Virol"},{"issue":"8","key":"819_CR28","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1128\/JVI.03507-12","volume":"87","author":"GQ Del Prete","year":"2013","unstructured":"Del Prete GQ, et al. Comparative characterization of transfection- and infection-derived simian immunodeficiency virus challenge stocks for in vivo nonhuman primate studies. J Virol. 2013;87(8):4584\u201395.","journal-title":"J Virol"},{"issue":"7238","key":"819_CR29","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nature07930","volume":"458","author":"JF Scheid","year":"2009","unstructured":"Scheid JF, et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature. 2009;458(7238):636\u201340.","journal-title":"Nature"},{"issue":"1","key":"819_CR30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0042-6822(03)00521-X","volume":"315","author":"S-H Xiang","year":"2003","unstructured":"Xiang S-H, et al. Epitope mapping and characterization of a novel CD4-induced human monoclonal antibody capable of neutralizing primary HIV-1 strains. Virology. 2003;315(1):124\u201334.","journal-title":"Virology"},{"issue":"2","key":"819_CR31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0092-8674(03)00508-7","volume":"114","author":"H Choe","year":"2003","unstructured":"Choe H, et al. Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120. Cell. 2003;114(2):161\u201370.","journal-title":"Cell"},{"issue":"6","key":"819_CR32","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1021\/bi035323x","volume":"43","author":"R Darbha","year":"2004","unstructured":"Darbha R, et al. Crystal structure of the broadly cross-reactive HIV-1-neutralizing fab X5 and fine mapping of its epitope. Biochemistry. 2004;43(6):1410\u20137.","journal-title":"Biochemistry"},{"issue":"9","key":"819_CR33","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1073\/pnas.0308527100","volume":"101","author":"C-C Huang","year":"2004","unstructured":"Huang C-C, et al. Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120. Proc Natl Acad Sci U S A. 2004;101(9):2706\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5846","key":"819_CR34","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1126\/science.1145373","volume":"317","author":"C-C Huang","year":"2007","unstructured":"Huang C-C, et al. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science (New York, N.Y.). 2007;317(5846):1930\u20134.","journal-title":"Science (New York, N.Y.)"},{"issue":"10","key":"819_CR35","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.1073\/pnas.102562599","volume":"99","author":"M Moulard","year":"2002","unstructured":"Moulard M, et al. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120\u2013CD4\u2013CCR5 complexes. Proc Natl Acad Sci U S A. 2002;99(10):6913\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"819_CR36","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0092-8674(00)80577-2","volume":"96","author":"M Farzan","year":"1999","unstructured":"Farzan M, et al. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell. 1999;96(5):667\u201376.","journal-title":"Cell"},{"issue":"4","key":"819_CR37","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.chom.2019.03.002","volume":"25","author":"N Alsahafi","year":"2019","unstructured":"Alsahafi N, et al. An asymmetric opening of HIV-1 envelope mediates antibody-dependent cellular cytotoxicity. Cell Host Microbe. 2019;25(4):578\u201387 e5.","journal-title":"Cell Host Microbe"},{"key":"819_CR38","doi-asserted-by":"publisher","unstructured":"Anand SP, Pr\u00e9vost J, Baril S, et al. Two Families of Env Antibodies Efficiently Engage Fc-Gamma Receptors and Eliminate HIV-1-Infected Cells. J Virol. 2019;93(3):e01823-18. https:\/\/doi.org\/10.1128\/JVI.01823-18.","DOI":"10.1128\/JVI.01823-18"},{"key":"819_CR39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1107\/S0021889800018227","volume":"34","author":"MS Weiss","year":"2001","unstructured":"Weiss MS. Global indicators of X-ray data quality. J Appl Crystallogr. 2001;34:130\u20135.","journal-title":"J Appl Crystallogr"},{"issue":"6084","key":"819_CR40","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1126\/science.1218231","volume":"336","author":"PA Karplus","year":"2012","unstructured":"Karplus PA, Diederichs K. Linking crystallographic model and data quality. Science. 2012;336(6084):1030\u20133.","journal-title":"Science"},{"issue":"Pt 1","key":"819_CR41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1107\/S0907444992007352","volume":"49","author":"AT Brunger","year":"1993","unstructured":"Brunger AT. Assessment of phase accuracy by cross validation: the free R value. Methods and applications. Acta Crystallogr D Biol Crystallogr. 1993;49(Pt 1):24\u201336.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"6","key":"819_CR42","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1101\/gr.849004","volume":"14","author":"GE Crooks","year":"2004","unstructured":"Crooks GE, et al. WebLogo: a sequence logo generator. Genome Res. 2004;14(6):1188\u201390.","journal-title":"Genome Res"},{"issue":"7209","key":"819_CR43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature07159","volume":"455","author":"J Liu","year":"2008","unstructured":"Liu J, et al. Molecular architecture of native HIV-1 gp120 trimers. Nature. 2008;455(7209):109\u201313.","journal-title":"Nature"},{"issue":"7","key":"819_CR44","volume":"8","author":"EE Tran","year":"2012","unstructured":"Tran EE, et al. Structural mechanism of trimeric HIV-1 envelope glycoprotein activation. PLoS Pathog. 2012;8(7):e1002797.","journal-title":"PLoS Pathog"},{"issue":"28","key":"819_CR45","doi-asserted-by":"crossref","first-page":"11440","DOI":"10.1073\/pnas.1101414108","volume":"108","author":"A Harris","year":"2011","unstructured":"Harris A, et al. Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures. Proc Natl Acad Sci U S A. 2011;108(28):11440\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"46","key":"819_CR46","doi-asserted-by":"crossref","first-page":"E7151","DOI":"10.1073\/pnas.1615939113","volume":"113","author":"H Wang","year":"2016","unstructured":"Wang H, et al. Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop. Proc Natl Acad Sci U S A. 2016;113(46):E7151\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"819_CR47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2016.06.026","volume":"45","author":"D Sok","year":"2016","unstructured":"Sok D, et al. A prominent site of antibody vulnerability on HIV envelope incorporates a motif associated with CCR5 binding and its camouflaging glycans. Immunity. 2016;45(1):31\u201345.","journal-title":"Immunity"},{"key":"819_CR48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jim.2016.03.002","volume":"433","author":"C Orlandi","year":"2016","unstructured":"Orlandi C, Flinko R, Lewis GK. A new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies. J Immunol Methods. 2016;433:51\u20138.","journal-title":"J Immunol Methods"},{"key":"819_CR49","doi-asserted-by":"publisher","unstructured":"Lee WS, Pr\u00e9vost J, Richard J, et al. CD4- and Time-Dependent Susceptibility of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity. J Virol. 2019;93(10):e01901-18. https:\/\/doi.org\/10.1128\/JVI.01901-18.","DOI":"10.1128\/JVI.01901-18"},{"key":"819_CR50","doi-asserted-by":"crossref","unstructured":"Richard J, et al. Uninfected bystander cells impact the measurement of HIV-specific antibody-dependent cellular cytotoxicity responses. MBio. 2018;9(2).","DOI":"10.1128\/mBio.00358-18"},{"issue":"1","key":"819_CR51","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/JVI.02868-14","volume":"89","author":"M Veillette","year":"2015","unstructured":"Veillette M, et al. The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals. J Virol. 2015;89(1):545\u201351.","journal-title":"J Virol"},{"issue":"4","key":"819_CR52","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1128\/JVI.02779-15","volume":"90","author":"S Ding","year":"2016","unstructured":"Ding S, et al. A highly conserved residue of the HIV-1 gp120 inner domain is important for antibody-dependent cellular cytotoxicity responses mediated by anti-cluster a antibodies. J Virol. 2016;90(4):2127\u201334.","journal-title":"J Virol"},{"key":"819_CR53","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jviromet.2014.08.003","volume":"208","author":"J Richard","year":"2014","unstructured":"Richard J, et al. Flow cytometry-based assay to study HIV-1 gp120 specific antibody-dependent cellular cytotoxicity responses. J Virol Methods. 2014;208:107\u201314.","journal-title":"J Virol Methods"},{"issue":"13","key":"819_CR54","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1128\/JVI.00347-16","volume":"90","author":"B von Bredow","year":"2016","unstructured":"von Bredow B, et al. Comparison of antibody-dependent cell-mediated cytotoxicity and virus neutralization by HIV-1 Env-specific monoclonal antibodies. J Virol. 2016;90(13):6127\u201339.","journal-title":"J Virol"},{"issue":"21","key":"819_CR55","doi-asserted-by":"crossref","first-page":"12895","DOI":"10.1128\/JVI.02194-14","volume":"88","author":"P Acharya","year":"2014","unstructured":"Acharya P, et al. Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infection. J Virol. 2014;88(21):12895\u2013906.","journal-title":"J Virol"},{"key":"819_CR56","doi-asserted-by":"crossref","unstructured":"Tolbert WD, et al. Structural basis for epitopes in the gp120 cluster A region that invokes potent effector cell activity. Viruses. 2019;11(1).","DOI":"10.3390\/v11010069"},{"issue":"4","key":"819_CR57","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.tim.2017.10.007","volume":"26","author":"J Richard","year":"2018","unstructured":"Richard J, et al. Impact of HIV-1 envelope conformation on ADCC responses. Trends Microbiol. 2018;26(4):253\u201365.","journal-title":"Trends Microbiol"},{"issue":"17","key":"819_CR58","doi-asserted-by":"crossref","first-page":"8840","DOI":"10.1128\/JVI.01232-15","volume":"89","author":"N Gohain","year":"2015","unstructured":"Gohain N, et al. Cocrystal structures of antibody N60-i3 and antibody JR4 in complex with gp120 define more cluster a epitopes involved in effective antibody-dependent effector function against HIV-1. J Virol. 2015;89(17):8840\u201354.","journal-title":"J Virol"},{"issue":"11","key":"819_CR59","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.str.2017.09.009","volume":"25","author":"WD Tolbert","year":"2017","unstructured":"Tolbert WD, et al. Targeting the late stage of HIV-1 entry for antibody-dependent cellular cytotoxicity: structural basis for Env epitopes in the C11 region. Structure. 2017;25(11):1719\u201331 e4.","journal-title":"Structure"},{"issue":"5","key":"819_CR60","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jmb.2011.04.023","volume":"410","author":"E Schnur","year":"2011","unstructured":"Schnur E, et al. The conformation and orientation of a 27-residue CCR5-peptide in a ternary complex with HIV-1 gp120 and a CD4-mimic peptide. J Mol Biol. 2011;410(5):778\u201397.","journal-title":"J Mol Biol"},{"issue":"9","key":"819_CR61","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1021\/cb500337r","volume":"9","author":"X Liu","year":"2014","unstructured":"Liu X, et al. Site-selective solid-phase synthesis of a CCR5 Sulfopeptide library to interrogate HIV binding and entry. ACS Chem Biol. 2014;9(9):2074\u201381.","journal-title":"ACS Chem Biol"},{"issue":"17","key":"819_CR62","doi-asserted-by":"crossref","first-page":"11031","DOI":"10.1073\/pnas.172380899","volume":"99","author":"C Seibert","year":"2002","unstructured":"Seibert C, et al. Tyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotransferases 1 and 2 follows a discrete pattern and temporal sequence. Proc Natl Acad Sci U S A. 2002;99(17):11031\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"819_CR63","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1021\/bi900285c","volume":"48","author":"CH Jen","year":"2009","unstructured":"Jen CH, Moore KL, Leary JA. Pattern and temporal sequence of sulfation of CCR5 N-terminal peptides by tyrosylprotein sulfotransferase-2: an assessment of the effects of N-terminal residues. Biochemistry. 2009;48(23):5332\u20138.","journal-title":"Biochemistry"},{"issue":"20","key":"819_CR64","doi-asserted-by":"crossref","first-page":"E2687","DOI":"10.1073\/pnas.1506755112","volume":"112","author":"J Richard","year":"2015","unstructured":"Richard J, et al. CD4 mimetics sensitize HIV-1-infected cells to ADCC. Proc Natl Acad Sci. 2015;112(20):E2687\u201394.","journal-title":"Proc Natl Acad Sci"},{"key":"819_CR65","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.3389\/fimmu.2018.03163","volume":"9","author":"SA Smith","year":"2018","unstructured":"Smith SA, et al. VH1-69 utilizing antibodies are capable of mediating non-neutralizing fc-mediated effector functions against the transmitted\/founder gp120. Front Immunol. 2018;9:3163.","journal-title":"Front Immunol"},{"key":"819_CR66","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.str.2013.04.015","volume":"21","author":"P Acharya","year":"2013","unstructured":"Acharya P, et al. Structural basis for highly effective HIV-1 neutralization by CD4-mimetic miniproteins revealed by 1.5 A cocrystal structure of gp120 and M48U1. Structure. 2013;21:1018\u201329.","journal-title":"Structure"},{"issue":"4","key":"819_CR67","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy AJ, et al. Phaser crystallographic software. J Appl Crystallogr. 2007;40(4):658\u201374.","journal-title":"J Appl Crystallogr"},{"issue":"17","key":"819_CR68","doi-asserted-by":"crossref","first-page":"8875","DOI":"10.1128\/JVI.76.17.8875-8889.2002","volume":"76","author":"RW Sanders","year":"2002","unstructured":"Sanders RW, et al. Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1. J Virol. 2002;76(17):8875\u201389.","journal-title":"J Virol"},{"issue":"1","key":"819_CR69","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1107\/S090744490705024X","volume":"64","author":"TC Terwilliger","year":"2008","unstructured":"Terwilliger TC, et al. Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard. Acta Crystallogr D Biol Crystallogr. 2008;64(1):61\u20139.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"12","key":"819_CR70","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004;60(12):2126\u201332.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"3","key":"819_CR71","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00002030-198903000-00006","volume":"3","author":"JP Moore","year":"1989","unstructured":"Moore JP, et al. An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1. Aids. 1989;3(3):155\u201363.","journal-title":"Aids"},{"issue":"3","key":"819_CR72","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1128\/JVI.03048-13","volume":"88","author":"K Ray","year":"2014","unstructured":"Ray K, et al. Antigenic properties of the HIV envelope on virions in solution. J Virol. 2014;88(3):1795\u2013808.","journal-title":"J Virol"}],"container-title":["BMC Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-020-00819-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12915-020-00819-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-020-00819-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T23:14:09Z","timestamp":1626822849000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiol.biomedcentral.com\/articles\/10.1186\/s12915-020-00819-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["819"],"URL":"https:\/\/doi.org\/10.1186\/s12915-020-00819-y","relation":{},"ISSN":["1741-7007"],"issn-type":[{"value":"1741-7007","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,21]]},"assertion":[{"value":"3 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"91"}}